Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In patients who have had type 1 diabetes for 5 years, current recommendations regarding screening for diabetic retinopathy include annual dilated retinal examinations to detect proliferative retinopathy or clinically significant macular edema, both of which require timely intervention to preserve vision. During 30 years of the Diabetes Control and Complications Trial (DCCT) and its longitudinal follow-up Epidemiology of Diabetes Interventions and Complications (EDIC) study, retinal photography was performed at intervals of 6 months to 4 years. METHODS: We used retinal photographs from the DCCT/EDIC study to develop a rational screening frequency for retinopathy. Markov modeling was used to determine the likelihood of progression to proliferative diabetic retinopathy or clinically significant macular edema in patients with various initial retinopathy levels (no retinopathy or mild, moderate, or severe nonproliferative diabetic retinopathy). The models included recognized risk factors for progression of retinopathy. RESULTS: Overall, the probability of progression to proliferative diabetic retinopathy or clinically significant macular edema was limited to approximately 5% between retinal screening examinations at 4 years among patients who had no retinopathy, 3 years among those with mild retinopathy, 6 months among those with moderate retinopathy, and 3 months among those with severe nonproliferative diabetic retinopathy. The risk of progression was also closely related to mean glycated hemoglobin levels. The risk of progression from no retinopathy to proliferative diabetic retinopathy or clinically significant macular edema was 1.0% over 5 years among patients with a glycated hemoglobin level of 6%, as compared with 4.3% over 3 years among patients with a glycated hemoglobin level of 10%. Over a 20-year period, the frequency of eye examinations was 58% lower with our practical, evidence-based schedule than with routine annual examinations, which resulted in substantial cost savings. CONCLUSIONS: Our model for establishing an individualized schedule for retinopathy screening on the basis of the patient's current state of retinopathy and glycated hemoglobin level reduced the frequency of eye examinations without delaying the diagnosis of clinically significant disease. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; DCCT/EDIC ClinicalTrials.gov numbers, NCT00360893 and NCT00360815 .).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nonhealing ulcers and bacterial infections increase the rate of progression of retinopathy,496,498”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [498]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Self-citationTurner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,006
The Theory of Stochastic Processes
Cox, D. R., Miller, H. D., Weiss, G., & Shuler, K. (1966) · Physics Today · doi:10.1063/1.3047872 · Cited by 3,324
(1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050120030015 · Cited by 2,540
Antonetti, D. A., Klein, R., & Gardner, T. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1005073 · Cited by 1,659
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
Lee, R., Wong, T. Y., & Sabanayagam, C. (2015) · Eye and Vision · doi:10.1186/s40662-015-0026-2 · Cited by 1,569
Research works printed but not linked: 1
- Wang JK, 2015, Eye Sci, 30, 176
Cited by
Items 101–141 of 141
Retinopathy, Neuropathy, and Foot Care
(2025) · American Diabetes Association eBooks · doi:10.2337/9781580408462-ch19 · Cited by 1
Puli, L., Piona, C. A., Mancioppi, V., Passanisi, S., Kavanagh, S., & Donaghue, K. C. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113385 · Cited by 1
Diabetic Retinopathy in Youth-Onset Type 2 Diabetes Mellitus
Richardson, E., & Farrell, R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-55138-0.00008-5 · Cited by 1
Detection of Optical Problem in Retinal Fundus Images Using AI Based Deep Learning Method
Durga, N., Hanirex, D. K., & Muthukumaravel, A. (2025) · Communications in computer and information science · doi:10.1007/978-3-031-86293-9_27 · Cited by 1
Long-term incidence and progression of vision-threatening diabetic retinopathy in Asian populations
Koh, B. M. Q. R., Chong, C., Tan, G. S. W., Cheng, C., & Sabanayagam, C. (2026) · Journal of Global Health · doi:10.7189/jogh.16.04174 · Cited by 1
“Both UK Prospective Diabetes Study (UKPDS) and the Diabetes Control and Complications Trial (DCCT) provided strong evidence that tight control of HbA1c 7% reduces the risk for progression of DR [ 20 , 25 ].”
Teshev, A. F., Malyshev, A. V., & Golovin, A. S. (2024) · Russian Medicine · doi:10.17816/medjrf624868 · Cited by 1
Sakai, M., Kato, T., Ishihara, T., Takao, K., Hirose, T., Kubota, S., Kubota‐Okamoto, S., Imaizumi, T., Takahashi, Y., Mizuno, M., et al. (2025) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2025.1590407 · Cited by 2
“In Japan, people with diabetes are advised to undergo at least one fundus examination per year; more frequent exams are recommended if DR is already present, glycemic control is inadequate, or diabetes duration exceeds 10 years (9, 10).”
Learning about diabetes through epidemiology
Balkau, B., & Holt, R. I. G. (2019) · Diabetic Medicine · doi:10.1111/dme.14120 · Cited by 2
Evaluating Diabetic Retinopathy Screening Interventions in a Microsimulation Model
Swan, B. P., Nambiar, S., Koutouan, P. R., Mayorga, M. E., Ivy, J. S., Fitts, E. P., & FRANSEN, S. R. (2020) · Winter Simulation Conference · doi:10.1109/wsc48552.2020.9384074 · Cited by 3
Larger, É. (2017) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(17)30102-5
Stadienabhängige Routine-Checks beim Augenarzt empfohlen
Holzgreve, H. (2017) · Info Diabetologie · doi:10.1007/s15034-017-1218-8
Charge glycémique : la mémoire du passé des diabétiques
Larger, É. (2018) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(18)30179-2
Dépistage des complications du diabète de type 1 chez l’enfant
Briet, C., & Allix, I. (2018) · Elsevier eBooks · doi:10.1016/b978-2-294-74942-1.00016-1
Shaping vessels and microenvironment: adipose stromal cells in retinal-related diseases
Terlizzi, V. (2019) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Byberg, S., Vistisen, D., Jørgensen, M. E., Díaz, L. J., Valerius, M., Hajari, J. N., & Lund‐Andersen, H. (2020) · Acta Ophthalmologica · doi:10.1111/aos.14590 · Cited by 1
De Micheli, A. (2019) · The Journal of AMD · doi:10.36171/jamd19.22.4.11
Llorente‐González, S. (2021) · Depósito Académico Digital Universidad de Navarra (University of Navarra) · doi:10.15581/10171/63224
Anderson, C., May, S., & Dedmon, D. D. (2022) · doi:10.21007/con.dnp.2022.0034
Plummer, E. S. (2022) · American Diabetes Association eBooks · doi:10.2337/9781580407700.ch06
Quality criteria for astigmatic aberrated fundus imagesPreprint
Георгиевич, И. Н., Ivanov, M., & Викторович, Л. А. (2023) · doi:10.1364/opticaopen.21917616
Quality criteria for astigmatic aberrated fundus imagesPreprint
Георгиевич, И. Н., Ivanov, M., & Викторович, Л. А. (2023) · doi:10.1364/opticaopen.21917616.v1
Generalized fiducial inference for the restricted mean survival time
Bebu, I., Diao, G., & Hamasaki, T. (2023) · Statistical Methods in Medical Research · doi:10.1177/09622802231163333
Future perspectives for diabetic retinopathy management
Li, W., & Zhang, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-93064-2.00006-8
Boyacı, İ., & Demirci, G. (2023) · Research Square · doi:10.21203/rs.3.rs-3239513/v1 · Cited by 2
Boyacı, İ., & Demirci, G. (2023) · Research Square · doi:10.21203/rs.3.rs-3239569/v1
Convolutional Neural Networks for Diabetic Retinopathy Grading from iPhone Fundus Images
Lozano-Juárez, S., Velasco-Pérez, N., Roberts, I., Gonzalez-Bernal, J. J., Basurto, N., Urda, D., & Herrero, Á. (2023) · Lecture notes in computer science · doi:10.1007/978-3-031-40725-3_58
Iklé, J. M., Addala, A., & Maahs, D. M. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch69
Current Treatment Approach to Diabetic Retinopathy
Küçüködük, A., & Kaya, F. (2023) · doi:10.69860/nobel.9786053359111.16
Bebu, I., Betensky, R. A., & Fay, M. P. (2024) · Clinical Trials · doi:10.1177/17407745241271939
Moodu, V., Chintha, R. P., Rebelli, S., Adeniyi, A. E., & Awotunde, J. B. (2025) · doi:10.2196/preprints.77945
Boyacı, İ., & Demirci, G. (2025) · Diagnostics · doi:10.3390/diagnostics15243185
“Notably, retinopathy may develop even under adequate glycemic control [16].”
Shamli, R., & Vasuki, P. (2026) · International Conference on Computing for Sustainable Global Development · doi:10.23919/indiacom70271.2026.11525594
Gardner, T. W. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-11985-9.00020-2
Beyond hyperglycaemia: diabetic retinopathy is a multifactorial complication of diabetes mellitus
Zou, Y., Yang, H., Lin, Y., Li, Q., Bao, Y., & Du, X. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2698364
“In addition to predicting severe complications, the primary clinical significance of DR screening lies in avoiding permanent visual loss, particularly in referable cases that require compre hensive prompt ophthalmic examination and treatment [10,140,141].”
Bhuiyan, A., Govindaiah, A., Otero-Marquez, O., Fabczak-Kubicka, A., Bhuiyan, T. R., Tai, K. W., Deobhakta, A. A., & Smith, T. (2026) · Scientific Reports · doi:10.1038/s41598-025-94866-6
酒井麻有 (2025) · Institutional Repositories DataBase (IRDB)
Set them free! Mehr Patienten mit weniger Kontrollen besser versorgen
Kellner, U., Geerling, G., & Hahn, U. (2026) · Die Ophthalmologie · doi:10.1007/s00347-026-02515-8
Tarek, M. F. B., Carroll, R. M., Flores, C., Henderer, J. D., & Beheshti, R. (2026) · Ophthalmology Science · doi:10.1016/j.xops.2026.101417
Diabetic cataract at type 1 diabetes onset: frequency and characteristics
Speidel, A. J., Krielen, M., Brandt-Heunemann, S., Wabitsch, M., Wolf, A., & Denzer, C. (2026) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2026-0545
“Current pediatric diabetes guidelines focus primarily on diabetic retinopathy screening and do not consistently address diabetic cataract as an acute or early ocular complication [29 – 31].”
Metadata
- Authors
- The DCCT/EDIC Research Group
- Affiliations
- Harvard University (US)
- Corresponding author
- The DCCT/EDIC Research Group
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-04-20
- Volume
- 376
- Issue
- 16
- Pages
- 1507-1516
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC5557280
- OpenAlex
- W2612354450
- Cited by
- 141
- References
- 35
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 11 · 2023: 15 · 2022: 20 · 2021: 14 · 2020: 20 · 2019: 14 · 2018: 18 · 2017: 8
- FWCI
- 16.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5u01dk094157-13, UL1TR001863)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK094176, U01-DK094157, P30DK036836, P30DK017047)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- diabetic retinopathy, type 1 diabetes, proliferative diabetic retinopathy, clinically significant macular edema, fundus photography, HbA1c, retinopathy progression, Markov model, cost reduction, DCCT/EDIC
- MeSH terms
- Adolescent, Adult, Diabetes Mellitus, Type 1, Diabetic Retinopathy, Follow-Up Studies, Glycated Hemoglobin, Humans, Macular Edema, Markov Chains, Photography, Retina, Risk Factors, Visual Acuity, Practice Guidelines as Topic, Disease Progression, Evidence-Based Medicine, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.